These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38145301)

  • 1. The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.
    Bellissimo CA; Gandhi S; Castellani LN; Murugathasan M; Delfinis LJ; Thuhan A; Garibotti MC; Seo Y; Rebalka IA; Hsu HH; Sweeney G; Hawke TJ; Abdul-Sater AA; Perry CGR
    Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1011-C1026. PubMed ID: 38145301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memory impairment in the D2.mdx mouse model of Duchenne muscular dystrophy is prevented by the adiponectin receptor agonist ALY688.
    Bellissimo CA; Castellani LN; Finch MS; Murugathasan M; Gandhi S; Sweeney G; Abdul-Sater AA; MacPherson REK; Perry CGR
    Exp Physiol; 2023 Sep; 108(9):1108-1117. PubMed ID: 37415288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H
    Hughes MC; Ramos SV; Turnbull PC; Rebalka IA; Cao A; Monaco CMF; Varah NE; Edgett BA; Huber JS; Tadi P; Delfinis LJ; Schlattner U; Simpson JA; Hawke TJ; Perry CGR
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):643-661. PubMed ID: 30938481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy.
    Hammers DW; Hart CC; Matheny MK; Wright LA; Armellini M; Barton ER; Sweeney HL
    Sci Rep; 2020 Aug; 10(1):14070. PubMed ID: 32826942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle.
    Dubuisson N; Versele R; Davis-López de Carrizosa MA; Selvais CM; Noel L; Planchon C; Van den Bergh PYK; Brichard SM; Abou-Samra M
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.
    Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC
    J Pathol; 2012 Sep; 228(1):77-87. PubMed ID: 22653783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.
    Gutpell KM; Hrinivich WT; Hoffman LM
    PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diaphragm muscle fibrosis involves changes in collagen organization with mechanical implications in Duchenne muscular dystrophy.
    Sahani R; Wallace CH; Jones BK; Blemker SS
    J Appl Physiol (1985); 2022 Mar; 132(3):653-672. PubMed ID: 35050792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial creatine sensitivity is lost in the D2.
    Bellissimo CA; Delfinis LJ; Hughes MC; Turnbull PC; Gandhi S; DiBenedetto SN; Rahman FA; Tadi P; Amaral CA; Dehghani A; Cobley JN; Quadrilatero J; Schlattner U; Perry CGR
    Am J Physiol Cell Physiol; 2023 May; 324(5):C1141-C1157. PubMed ID: 36689672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
    Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
    EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy.
    Whitehead NP; Bible KL; Kim MJ; Odom GL; Adams ME; Froehner SC
    J Physiol; 2016 Dec; 594(24):7215-7227. PubMed ID: 27570057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myofibrillar Lattice Remodeling Is a Structural Cytoskeletal Predictor of Diaphragm Muscle Weakness in a Fibrotic
    Ritter P; Nübler S; Buttgereit A; Smith LR; Mühlberg A; Bauer J; Michael M; Kreiß L; Haug M; Barton E; Friedrich O
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse.
    Gibertini S; Zanotti S; Savadori P; Curcio M; Saredi S; Salerno F; Andreetta F; Bernasconi P; Mantegazza R; Mora M
    Cell Tissue Res; 2014 May; 356(2):427-43. PubMed ID: 24723230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensorimotor control of breathing in the mdx mouse model of Duchenne muscular dystrophy.
    Burns DP; Roy A; Lucking EF; McDonald FB; Gray S; Wilson RJ; Edge D; O'Halloran KD
    J Physiol; 2017 Nov; 595(21):6653-6672. PubMed ID: 28952155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bowman-Birk inhibitor attenuates dystrophic pathology in mdx mice.
    Morris CA; Selsby JT; Morris LD; Pendrak K; Sweeney HL
    J Appl Physiol (1985); 2010 Nov; 109(5):1492-9. PubMed ID: 20847128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in calsequestrin, TNF-α, TGF-β and MyoD levels during the progression of skeletal muscle dystrophy in mdx mice: a comparative analysis of the quadriceps, diaphragm and intrinsic laryngeal muscles.
    Barros Maranhão J; de Oliveira Moreira D; Maurício AF; de Carvalho SC; Ferretti R; Pereira JA; Santo Neto H; Marques MJ
    Int J Exp Pathol; 2015 Oct; 96(5):285-93. PubMed ID: 26515458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice.
    Hinkle RT; Lefever FR; Dolan ET; Reichart DL; Dietrich JA; Gropp KE; Thacker RI; Demuth JP; Stevens PJ; Qu XA; Varbanov AR; Wang F; Isfort RJ
    BMC Med; 2007 Jul; 5():18. PubMed ID: 17626629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preserved Left Ventricular Function despite Myocardial Fibrosis and Myopathy in the Dystrophin-Deficient D2.B10-Dmd
    Hayes HM; Angerosa J; Piers AT; White JD; Koleff J; Thurgood M; Moody J; Cheung MM; Pepe S
    Oxid Med Cell Longev; 2022; 2022():5362115. PubMed ID: 35340200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.